Cameron Turtle, Chief Business Officer at Eidos Therapeutics, Inc. (EIDX), sold 12,800 shares at $39.05 ($509K) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $509k EIDX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.05 | 2,800 | $109K | 21.5% |
| 2 | $39.05 | 2,800 | $109K | 21.5% |
| 3 | $40.25 | 6,700 | $270K | 53.0% |
| 4 | $40.89 | 500 | $20K | 4.0% |
| Total | $39.75 avg | 12,800 | $509K | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $1.4M | — | Filing → |
| SYRE | SELL | 2026-07-02 | $1.3M | — | Filing → |
| SYRE | SELL | 2026-06-03 | $1.1M | — | Filing → |